BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18085824)

  • 1. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.
    Yu X; Wang Z; Mertz JE
    PLoS Pathog; 2007 Dec; 3(12):e194. PubMed ID: 18085824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.
    Ellis AL; Wang Z; Yu X; Mertz JE
    J Virol; 2010 Jun; 84(12):6139-52. PubMed ID: 20375168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus.
    Yu X; McCarthy PJ; Wang Z; Gorlen DA; Mertz JE
    J Virol; 2012 Aug; 86(15):8086-96. PubMed ID: 22623769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
    Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
    Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells.
    Feng WH; Kraus RJ; Dickerson SJ; Lim HJ; Jones RJ; Yu X; Mertz JE; Kenney SC
    J Virol; 2007 Sep; 81(18):10113-22. PubMed ID: 17626078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
    J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
    Ellis-Connell AL; Iempridee T; Xu I; Mertz JE
    J Virol; 2010 Oct; 84(19):10329-43. PubMed ID: 20668090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L; Kwa D; El-Guindy A; Miller G
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.
    Kraus RJ; Yu X; Cordes BA; Sathiamoorthi S; Iempridee T; Nawandar DM; Ma S; Romero-Masters JC; McChesney KG; Lin Z; Makielski KR; Lee DL; Lambert PF; Johannsen EC; Kenney SC; Mertz JE
    PLoS Pathog; 2017 Jun; 13(6):e1006404. PubMed ID: 28617871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency.
    Yu X; McCarthy PJ; Lim HJ; Iempridee T; Kraus RJ; Gorlen DA; Mertz JE
    J Virol; 2011 May; 85(10):5081-90. PubMed ID: 21389123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Perrigoue JG; Mertz JE
    J Virol; 2003 Jan; 77(1):199-207. PubMed ID: 12477825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.
    Nawandar DM; Ohashi M; Djavadian R; Barlow E; Makielski K; Ali A; Lee D; Lambert PF; Johannsen E; Kenney SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
    Romero-Masters JC; Huebner SM; Ohashi M; Bristol JA; Benner BE; Barlow EA; Turk GL; Nelson SE; Baiu DC; Van Sciver N; Ranheim EA; Gumperz J; Sherer NM; Farrell PJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Feb; 16(2):e1008365. PubMed ID: 32059024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome.
    Dunn LEM; Lu F; Su C; Lieberman PM; Baines JD
    J Virol; 2023 Feb; 97(2):e0189422. PubMed ID: 36744959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.
    Kraus RJ; Cordes BA; Sathiamoorthi S; Patel P; Yuan X; Iempridee T; Yu X; Lee DL; Lambert PF; Mertz JE
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
    Countryman JK; Gradoville L; Miller G
    J Virol; 2008 May; 82(10):4706-19. PubMed ID: 18337569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV-immortalized isogenic human B-cell clones exhibit differences in DNA-protein complex formation on the BZLF1 and BRLF1 promoter regions among latent, lytic and TPA-activated cell lines.
    Cen H; McKnight JL
    Virus Res; 1994 Jan; 31(1):89-107. PubMed ID: 8165871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching of EBV cycles between latent and lytic states.
    Murata T; Tsurumi T
    Rev Med Virol; 2014 May; 24(3):142-53. PubMed ID: 24339346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.